Leading 10 U.S. therapy areas based on drug spending in 2020* (in billion U.S. dollars)
Loading statistic...
Basic Account
Get to know the platform
You only have access to basic statistics.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you U.S. pharmaceutical industry
Contribution to global pharma
5
- Premium Statistic World pharmaceutical market distribution by submarket 2014-2023
- Premium Statistic World pharmaceutical sales 2020-2023 by region
- Basic Statistic Market share of the leading global pharmaceutical markets 2022
- Premium Statistic Top global pharmaceutical markets: growth rate 2022
- Premium Statistic Top 50 pharmaceutical companies - Rx sales and R&D spending 2022
Overview
6
- Premium Statistic U.S. total medicine spending 2002-2022
- Basic Statistic Leading therapy areas for U.S. drug spending 2020
- Premium Statistic U.S. top prescribed drugs based on sales 2022
- Premium Statistic Top pharma products by prescriptions U.S. 2021
- Premium Statistic Pharmaceutical channel distribution by U.S. spending 2017-2019
- Premium Statistic U.S. biopharmaceutical export volume 2002-2022
Companies
6
- Premium Statistic 2024 list of top U.S. biotech and pharmaceutical companies based on revenue
- Premium Statistic Pharmaceutical corporations by U.S. revenue 2022
- Basic Statistic AbbVie's revenue 2010-2023
- Premium Statistic Pfizer's total revenue 2006-2023
- Premium Statistic Bristol-Myers Squibb's revenue 2006-2023
- Premium Statistic Johnson & Johnson's total sales 2005-2023
Research and development
7
- Basic Statistic Research and development expenditure: U.S. pharmaceutical industry 1995-2022
- Premium Statistic U.S. pharma industry R&D spending as a percent of total revenues 1990-2022
- Basic Statistic Pharmaceuticals: cost of drug development in the U.S. since 1975
- Premium Statistic Number of novel drugs approved annually by CDER 2008-2023
- Premium Statistic Number of orphan designations accepted in the U.S. 2003-2023
- Basic Statistic U.S. sales of new brand medicines 2012-2021
- Basic Statistic R&D expenditure per employee in U.S. sectors 2003-2017
Generics
5
- Basic Statistic Spending change on branded and generic medicines in the U.S. 2014-2021
- Premium Statistic U.S. brand and generic prescription drug spending 2017-2021
- Premium Statistic Branded vs. generic U.S. drug prescriptions dispensed 2005-2021
- Premium Statistic Savings through generic drug usage in the U.S. 2008-2022
- Premium Statistic Sales share at risk of pharmaceuticals due to patent expiries U.S. 2022
Public view on pharma
6
- Premium Statistic Share of U.S. people who had a favorable view of pharmaceutical companies 2021
- Premium Statistic U.S. approval of pharma companies' COVID-19 vaccine development handling 2021
- Premium Statistic Share of U.S. adults who approve pharmaceutical companies' drug price handling 2021
- Basic Statistic Share of people who had a favorable view of Pfizer in U.S. 2021
- Basic Statistic Share of people who had a favorable view of Moderna in U.S. 2021
- Premium Statistic Share of people who had a favorable view of J&J in U.S. 2021
Outlook
4
- Premium Statistic World pharmaceutical sales by region forecast 2027
- Premium Statistic Sales at risk of pharmaceuticals due to patent expiries U.S. 2022
- Basic Statistic Leading U.S. pharmaceutical products by revenue 2026
- Basic Statistic U.S. cannabinoid-based pharmaceuticals market size 2020-2029 projection
Further related statistics
18
- New medicine availability by therapy area worldwide 2013
- Drugs in development with potential to be first-in-class in 2016, by therapeutic area
- Volume of the ten best-selling drugs in France 2015, by active ingredient
- Volume of the ten best-selling drugs in France 2015, by packaging
- Payment method for prescriptions dispensed in the U.S. 2016-2021
- Distribution of Sino Biopharm revenue 2022, by product category
- Global pharmaceutical pipeline by therapy area 2013-2017
- Rx medicine out-of-pocket expense per person in the U.S. 1987-2014
- Global pharmaceutical product launches by therapy area 2004-2013
- U.S. costs saved through generics by therapy 2004-2013
- Total and per capita change in U.S. prescriptions 2004-2013
- Top therapy spending areas in pharmerging markets 2018
- Prescription per capita in the United States by age group 2013
- Prescribed medicines usage in the Netherlands 2022, by type
- Reasons for rejected payer retail prescriptions in the U.S. in select classes 2013
- Monthly value of medicament exports from Iceland 2022-2024
- Children's medicine recalls by manufacturer in the U.S. 2015
- Oncology medicines sales in the United States 2010-2019
Further Content: You might find this interesting as well
Statistics
- New medicine availability by therapy area worldwide 2013
- Drugs in development with potential to be first-in-class in 2016, by therapeutic area
- Volume of the ten best-selling drugs in France 2015, by active ingredient
- Volume of the ten best-selling drugs in France 2015, by packaging
- Payment method for prescriptions dispensed in the U.S. 2016-2021
- Distribution of Sino Biopharm revenue 2022, by product category
- Global pharmaceutical pipeline by therapy area 2013-2017
- Rx medicine out-of-pocket expense per person in the U.S. 1987-2014
- Global pharmaceutical product launches by therapy area 2004-2013
- U.S. costs saved through generics by therapy 2004-2013
- Total and per capita change in U.S. prescriptions 2004-2013
- Top therapy spending areas in pharmerging markets 2018
- Prescription per capita in the United States by age group 2013
- Prescribed medicines usage in the Netherlands 2022, by type
- Reasons for rejected payer retail prescriptions in the U.S. in select classes 2013
- Monthly value of medicament exports from Iceland 2022-2024
- Children's medicine recalls by manufacturer in the U.S. 2015
- Oncology medicines sales in the United States 2010-2019
IQVIA. (May 27, 2021). Leading 10 U.S. therapy areas based on drug spending in 2020* (in billion U.S. dollars) [Graph]. In Statista. Retrieved June 18, 2024, from https://www.statista.com/statistics/238698/us-health-spending-leading-areas/
IQVIA. "Leading 10 U.S. therapy areas based on drug spending in 2020* (in billion U.S. dollars)." Chart. May 27, 2021. Statista. Accessed June 18, 2024. https://www.statista.com/statistics/238698/us-health-spending-leading-areas/
IQVIA. (2021). Leading 10 U.S. therapy areas based on drug spending in 2020* (in billion U.S. dollars). Statista. Statista Inc.. Accessed: June 18, 2024. https://www.statista.com/statistics/238698/us-health-spending-leading-areas/
IQVIA. "Leading 10 U.S. Therapy Areas Based on Drug Spending in 2020* (in Billion U.S. Dollars)." Statista, Statista Inc., 27 May 2021, https://www.statista.com/statistics/238698/us-health-spending-leading-areas/
IQVIA, Leading 10 U.S. therapy areas based on drug spending in 2020* (in billion U.S. dollars) Statista, https://www.statista.com/statistics/238698/us-health-spending-leading-areas/ (last visited June 18, 2024)
Leading 10 U.S. therapy areas based on drug spending in 2020* (in billion U.S. dollars) [Graph], IQVIA, May 27, 2021. [Online]. Available: https://www.statista.com/statistics/238698/us-health-spending-leading-areas/